Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KDNY

Chinook Therapeutics (KDNY) Stock Price, News & Analysis

Chinook Therapeutics logo

About Chinook Therapeutics Stock (NASDAQ:KDNY)

Advanced Chart

Key Stats

Today's Range
$40.39
$40.39
50-Day Range
$38.66
$40.39
52-Week Range
$18.34
$40.51
Volume
N/A
Average Volume
1.19 million shs
Market Capitalization
$2.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KDNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chinook Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KDNY Stock News Headlines

Three Finalists Announced for the 2024 Bloom Burton Award
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Chinook Elementary
Chinook Therapeutics, Inc. (KDNY)
Expert Ratings for Chinook Therapeutics
See More Headlines

KDNY Stock Analysis - Frequently Asked Questions

Chinook Therapeutics, Inc. (NASDAQ:KDNY) announced its earnings results on Tuesday, May, 9th. The company reported ($0.85) EPS for the quarter, missing analysts' consensus estimates of ($0.82) by $0.03. Chinook Therapeutics's quarterly revenue was down 32.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chinook Therapeutics investors own include Advanced Micro Devices (AMD), Meta Platforms (META), NIO (NIO), Ovintiv (OVV), Plug Power (PLUG), AMC Entertainment (AMC) and Applied Materials (AMAT).

Company Calendar

Last Earnings
5/09/2023
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:KDNY
Fax
N/A
Employees
214
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$187.87 million
Net Margins
-4,199.93%
Pretax Margin
-4,115.56%

Debt

Sales & Book Value

Annual Sales
$6.13 million
Price / Cash Flow
N/A
Book Value
$6.91 per share
Price / Book
5.85

Miscellaneous

Free Float
59,749,000
Market Cap
$2.90 billion
Optionable
Optionable
Beta
0.34
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:KDNY) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners